U.S. Markets open in 9 hrs 17 mins

Cryoport, Inc. (CYRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
46.18+0.71 (+1.56%)
At close: 4:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close45.47
Bid45.18 x 900
Ask47.48 x 1200
Day's Range45.06 - 47.63
52 Week Range13.01 - 63.36
Avg. Volume954,679
Market Cap1.832B
Beta (5Y Monthly)1.32
PE Ratio (TTM)N/A
EPS (TTM)-0.59
Earnings DateNov 05, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est53.86
  • 2 COVID-19 Vaccine Plays You May Not Know

    2 COVID-19 Vaccine Plays You May Not Know

    Think it's too late to get in and profit on the vaccine rally? It might not be. Pfizer (NYSE: PFE), BioNTech (NASDAQ: BNTX) and Moderna (NASDAQ: MRNA) all recently announced positive data from their respective vaccine trials and rallied, but other companies could be traded on their news as well.There are two main concerns surrounding the vaccine candidates: efficacy and transportation. Between the two candidates, efficacy looks good, but Moderna appears to outperform Pfizer and BioNTech's candidate with ease of transportation.Here's 2 vaccine plays that you probably haven't heard of:CryoPort (NASDAQ: CYRX) takes advantage of the ease of transportation aspect of the vaccine candidates.The company provides temperature-controlled supply chain solutions and could help transport vaccine candidates that need to stay within a certain temperature range. It traded lower today because Moderna announced its vaccine can remain stable while refrigerated, whereas Pfizer's has to be kept at a lower temperature.TOMI Environmental Solutions (NASDAQ: TOMZ) provides decontamination and infectious disease control products and services. It provides environmental solutions for indoor and outdoor surface decontamination through the sale of equipment, services and licensing.Multiple vaccines with high efficacy could decrease demand for decontamination and infectious disease control products and services. If you're expecting more positive vaccine news, you could short these stocks or buy put options in them as might continue to trade lower. If you're expecting negative vaccine news, you could buy these stocks or buy call options in them, as they might rebound and trade higher.See more from Benzinga * Click here for options trades from Benzinga * 16 Stocks Moving In Monday's After-Hours Session * 'Halftime Report' Final Trades: Upwork, Starbucks And More(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Cryoport Reports 2020 Third-Quarter Results
    PR Newswire

    Cryoport Reports 2020 Third-Quarter Results

    Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport", "our" or "we"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced financial results for the Third Quarter and nine-month period ended September 30, 2020.


    CryoPort, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / November 5, 2020 / CryoPort, Inc.